Andrea Riposati, Dante Labs

The Italian Innovator Using Whole Genomic Sequencing to Combat COVID-19

In this new Pandemic Response series, StartUp Health’s senior writer, Nicole Clark talks with Italy-based Andrea Riposati, CEO of Dante Labs, about how his DNA tests are being used to sequence the whole genome of patients with COVID-19. His aim? To understand what genes play a role in our reaction to the deadly disease.

Entrepreneurs: How to get investment from StartUp Health
Investors: How to invest in StartUp Health Moonshots

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.